Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine (Q45052993)

9 December 2017

Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine (English)

1 reference

9 December 2017

0 references

7

1 reference

9 December 2017

Roberto Cavallaro

2

0 references

Giovanna Rizzo

object named as

Giovanna Rizzo

9

0 references

Cristina Colombo

object named as

Cristina Colombo

8

0 references

Enrico Smeraldi

11

object named as

Enrico Smeraldi

1 reference

9 December 2017

Rosa Maria Moresco

1

1 reference

9 December 2017

Cristina Messa

3

1 reference

9 December 2017

Daniele Bravi

4

1 reference

9 December 2017

Clara Gobbo

5

1 reference

9 December 2017

Laura Galli

6

1 reference

9 December 2017

Isabella Velonà

10

1 reference

9 December 2017

Ferruccio Fazio

12

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Journal of Psychopharmacology

9 December 2017

1 reference

9 December 2017

18

1 reference

9 December 2017

3

1 reference

9 December 2017

355-365

1 reference

A review of central 5-HT receptors and their function

9 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

The role of serotonin in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Serotonin, schizophrenia and antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Dopamine D(2) receptor blockade in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Comparing functional (PET) images: the assessment of significant change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

In vitro pharmacological profile of 3-N-(2-fluoroethyl)spiperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

5-HT2 antagonism and EPS benefits: is there a causal connection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): health economic results of an international naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Robust Smoothness Estimation in Statistical Parametric Maps Using Standardized Residuals from the General Linear Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Probing targets for antipsychotic drug action with PET and SPET receptor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Elevation of prolactin levels by atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

A three-dimensional statistical analysis for CBF activation studies in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110401800306

10.1177/026988110401800306

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference